Cargando…
Revisiting inconsistency in large pharmacogenomic studies
In 2013, we published a comparative analysis of mutation and gene expression profiles and drug sensitivity measurements for 15 drugs characterized in the 471 cancer cell lines screened in the Genomics of Drug Sensitivity in Cancer (GDSC) and Cancer Cell Line Encyclopedia (CCLE). While we found good...
Autores principales: | Safikhani, Zhaleh, Smirnov, Petr, Freeman, Mark, El-Hachem, Nehme, She, Adrian, Rene, Quevedo, Goldenberg, Anna, Birkbak, Nicolai J., Hatzis, Christos, Shi, Leming, Beck, Andrew H., Aerts, Hugo J.W.L., Quackenbush, John, Haibe-Kains, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580432/ https://www.ncbi.nlm.nih.gov/pubmed/28928933 http://dx.doi.org/10.12688/f1000research.9611.3 |
Ejemplares similares
-
Assessment of pharmacogenomic agreement
por: Safikhani, Zhaleh, et al.
Publicado: (2016) -
Creating reproducible pharmacogenomic analysis pipelines
por: Mammoliti, Anthony, et al.
Publicado: (2019) -
Gene isoforms as expression-based biomarkers predictive of drug response in vitro
por: Safikhani, Zhaleh, et al.
Publicado: (2017) -
Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro
por: Safikhani, Zhaleh, et al.
Publicado: (2018) -
Machine learning approaches to drug response prediction: challenges and recent progress
por: Adam, George, et al.
Publicado: (2020)